<産業資料/調査レポートの題名> 2022年7月15日

腫瘍アブレーションの世界市場:技術別(ラジオ波、マイクロ波、冷凍アブレーション、その他)、治療方法別(手術アブレーション、腹腔鏡アブレーション、経皮アブレーション)、用途別(肝臓がん、肺がん、腎臓がん、その他)


◆英文タイトル:Global Tumor Ablation Market Size study, by Technology (Radiofrequency, Microwave, Cryoablation, Others), by Mode of Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), by Application (Liver Cancer, Lung Cancer, Kidney Cancer, Others) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Tumor Ablation Market, by Technology, 2017-2026 (USD Million)
1.2.2. Tumor Ablation Market, by Mode of Treatment, 2017-2026 (USD Million)
1.2.3. Tumor Ablation Market, by Application, 2017-2026 (USD Million)
1.2.4. Tumor Ablation Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tumor Ablation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tumor Ablation Market Dynamics
3.1. Tumor Ablation Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Tumor Ablation Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Tumor Ablation Market, by Technology
5.1. Market Snapshot
5.2. Global Tumor Ablation Market by Technology, Performance – Potential Analysis
5.3. Global Tumor Ablation Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
5.4. Tumor Ablation Market, Sub Segment Analysis
5.4.1. Radiofrequency
5.4.2. Microwave
5.4.3. Cryoablation
5.4.4. Others
Chapter 6. Global Tumor Ablation Market, by Mode of Treatment
6.1. Market Snapshot
6.2. Global Tumor Ablation Market by Mode of Treatment, Performance – Potential Analysis
6.3. Global Tumor Ablation Market Estimates & Forecasts by Mode of Treatment, 2016-2026 (USD Million)
6.4. Tumor Ablation Market, Sub Segment Analysis
6.4.1. Surgical Ablation
6.4.2. Laparoscopic Ablation
6.4.3. Percutaneous Ablation
Chapter 7. Global Tumor Ablation Market, by Application
7.1. Market Snapshot
7.2. Global Tumor Ablation Market by Application, Performance – Potential Analysis
7.3. Global Tumor Ablation Market Estimates & Forecasts by Application, 2016-2026 (USD Million)
7.4. Tumor Ablation Market, Sub Segment Analysis
7.4.1. Liver Cancer
7.4.2. Lung Cancer
7.4.3. Kidney Cancer
7.4.4. Others
Chapter 8. Global Tumor Ablation Market, Regional Analysis
8.1. Tumor Ablation Market, Regional Market Snapshot
8.2. North America Tumor Ablation Market
8.2.1. U.S. Tumor Ablation Market
8.2.1.1. Technology breakdown estimates & forecasts, 2016-2026
8.2.1.2. Mode of Treatment breakdown estimates & forecasts, 2016-2026
8.2.1.3. Application breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Tumor Ablation Market
8.3. Europe Tumor Ablation Market Snapshot
8.3.1. U.K. Tumor Ablation Market
8.3.2. Rest of Europe Tumor Ablation Market
8.4. Asia-Pacific Tumor Ablation Market Snapshot
8.4.1. China Tumor Ablation Market
8.4.2. India Tumor Ablation Market
8.4.3. Japan Tumor Ablation Market
8.4.4. Rest of Asia Pacific Tumor Ablation Market
8.5. Latin America Tumor Ablation Market Snapshot
8.5.1. Brazil Tumor Ablation Market
8.5.2. Mexico Tumor Ablation Market
8.6. Rest of The World Tumor Ablation Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Medtronic, PLC.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject To Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Angiodynamics, Inc.
9.2.3. Healthtronics, Inc.
9.2.4. Galil Medical, Inc.
9.2.5. Boston Scientific Corporation
9.2.6. Neuwave Medical, Inc.
9.2.7. Edap Tms S.A.
9.2.8. Mermaid Medical A/S
9.2.9. Sonacare Medical, LLC
9.2.10. Misonix, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark